Drugs
Recent research from Kyoto University has shed light on innovative studies related to cancer, hair loss, and diabetes. In Study 1, researchers discuss the early stages of human T-cell leukemia virus type 1 infection in human lymphocytes using the human PBMC-NOG mouse model. The study reveals that the human PBMC-NOG
Drugs
Harvard University researchers have made significant contributions to the understanding of various diseases, shedding light on potential therapeutic approaches. A recent investigation discovered distinct structural and functional properties of the ATPase sites in an asymmetric ABC transporter, which has implications for understanding the transport of peptides into the endoplasmic reticulum.
Drugs
University of Bristol researchers in England have published new study data on health trends and antioxidants, finding potential links between childhood body mass index (BMI), adult insulin-like growth factor (IGF) levels, and chronic disease risk. Additionally, a second study suggests that highly active antiretroviral therapy (HAART) has improved virological response
Drugs
Research from the University of Texas, U.S., has been shedding light on various aspects of molecular imaging, DNA ligase activity, and uric acid nephrolithiasis. The studies have shown promising results in the fields of cancer research, embryonic development, and diabetes management. Key Takeaways: * Recent research from the University of
Drugs
Researchers at Sahlgrenska University, Sweden have made significant discoveries in the fields of immunology, cardiology, and oncology, shedding light on new treatment options and mechanisms for various diseases. These breakthroughs highlight the ongoing efforts of the university to push the boundaries of medical research and advance the field of healthcare.
Drugs
Researchers at the University of Texas, M.D. Anderson Cancer Center, have made significant progress in understanding and treating various forms of cancer. According to recent studies, a tyrosine kinase inhibitor has shown promise in reducing lymph node metastasis in colon cancer, while early identification and treatment of cancer-treatment-induced bone
Drugs
Merck KGaA, a pharmaceutical company, has recently entered into an agreement with Glenmark Pharmaceuticals for the development and commercialization of Glenmark's DPPIV inhibitor GRC 8200, a treatment for type 2 diabetes. Separately, Merck & Co. announced that the U.S. Food and Drug Administration (FDA) has approved Gardasil,
Drugs
Researchers at Memorial Sloan-Kettering Cancer Center in New York City, U.S., have made significant discoveries in the field of cancer treatment. Studies conducted by the center's scientists have shed light on new approaches to understanding and combating various types of cancer. Key Takeaways: * Serum interleukin-12:interleukin-6 ratio
Universities and colleges
Pioneering research by investigators at the University of Texas has led to significant breakthroughs in medical science. Studies on anticoagulation therapy and cancer treatment have shed new light on the prevention of postoperative strokes after coronary artery bypass grafting surgery and the inhibition of angiogenesis in cancer. According to the
Universities and colleges
Researchers at Johns Hopkins University have made significant breakthroughs in the fields of stem cells, cancer surveillance, and colon cancer prevention. Study 1 explores the expansion of human hematopoietic stem and progenitor cells in a 3-dimensional scaffold with surface-immobilized fibronectin, demonstrating a synergistic effect that enhances cell expansion efficiency. Study
Universities and colleges
Researchers from the University of Groningen in the Netherlands have published three studies that describe new diagnostic tools for cancer and metabolic stress. The first study found that quantitative methylation-specific PCR (QMSP) of hypermethylated genes is a promising tool for identifying squamous cell cervical cancer. The second study discovered that
Universities and colleges
Researchers at The University of Texas M. D. Anderson Cancer Center have made significant advancements in understanding and treating various types of cancer. Recent studies have shed light on the potential of a genetic biomarker for selecting among chemotherapy choices for non-small-cell lung cancer, the benefits of exercise for breast
